Across TCGA pan-cancer cohorts, LINC01973 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC01973 data layer compared with 24 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01973 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01973 expression acts as an unfavorable survival marker.
COAD and ESCA are the cancer types where LINC01973 Mutation most reproducibly stratifies survival.